Starting the week of Sept. 20, Americans who got the Pfizer or Moderna vaccine against COVID-19 will be eligible to statement Wednesday from public health and medical experts at the US Department of Health and Human Services.eight months after their second dose, according to a
The statement, which included experts from the Centers for Disease Control and Prevention and the Food and Drug Administration, cited evidence that vaccine effectiveness could lessen over time.
“Based on our latest assessment, the current protection against severe disease, hospitalization, and death could diminish in the months ahead, especially among those who are at higher risk or were vaccinated during the earlier phases of the vaccination rollout,” said officials in the joint statement. “We conclude that a booster shot will be needed to maximize vaccine-induced protection and prolong its durability.”
The plan is subject to FDA approval and CDC recommendation on dosage.
“Thanks to the aggressive actions we have taken to establish our vaccination program, it will be just as easy and convenient to get a booster shot as it is to get a first shot today,” said Jeff Zients, White House COVID-19 response coordinator, during a briefing on Wednesday, adding that “boosters will be free regardless of immigration or health insurance status.”
The news comes as the more contagiouscontinues to spread around the US. Even though caused by the delta variant amount to less than 1% of the total, a CDC study showed that can both get it and spread it, raising concerns over how to further control the virus.
The FDA and CDC last week signed off on an extra shot of the Pfizer or Moderna COVID-19 vaccines for some immunocompromised people, including solid organ transplant recipients and people receiving treatment for cancers of the blood.
Those who received the Johnson & Johnson vaccine aren’t eligible for a booster shot just yet. Health officials said they anticipate a booster will be needed but are waiting on more data, expected in the next few weeks, to create a plan for J&J booster shots.
According to CDC data, about 168.9 million people in the US are , or 50.9% of the population.
“Our top priority remains staying ahead of the virus and protecting the American people from COVID-19 with safe, effective, and long-lasting vaccines especially in the context of a constantly changing virus and epidemiologic landscape,” said health officials in the joint statement.